Adenocarcinoma of the Esophagogastric Junction
Buch in deiner Nähe kaufen
Beschreibung
Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. Accordingly, much effort is being devoted to basic and translational research in order to combat this frequently deadly disease.
This special volume, with contributions from experts in the field, covers all aspects of adenocarcinomas of the esophagogastric junction. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are also addressed. Detailed attention is paid to other important recent developments, including molecular response prediction in multimodality treatment and early metabolic response evaluation by PET and PET-CT during neoadjuvant treatment. The diagnosis of micrometastases and its potential impact on therapeutic strategies are explored, and the use of sentinel node technology is assessed. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy.
Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. This special volume, with contributions from experts in the field, covers all aspects of the disease. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are addressed. Detailed attention is also paid to other important recent developments, including molecular response prediction, early metabolic response evaluation by PET and PET-CT, the diagnosis of micrometastases, and the use of sentinel node technology. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy.
Provides detailed coverage of etiology, pathogenesis, classification, and clinical staging Focuses in particular on state of the art treatment techniques, ranging from endoscopic mucosal resections or limited surgical resections to multimodality treatment options Discusses molecular response prediction, early metabolic response evaluation, the diagnosis of micrometastases, and the use of sentinel node technology Includes supplementary material: sn.pub/extras
Autor*in
Paul M. Schneider
Themen in »Adenocarcinoma of the Esophagogastric Junction«
Atmen Barrett's metaplasia Esophageal adenocarcinoma Mucosal resection Sentinal lymph node biopsy Staging biopsy carcinoma classification endoscopy surgery
Stimmen zu »Adenocarcinoma of the Esophagogastric Junction«
From the reviews:
“Adenocarcinoma of the Esophagogastric Junction provides today’s most comprehensive and tailored description of the pathogenesis, diagnosis, staging, and therapy of malignancy of a single region within the upper digestive tract. … The chapters are succinct and well written, and the topics follow a logical progression of thought. … one reads through, a sense of ‘order’ is appreciated and this ultimately frames the barriers that exist in the care of these patients. I left this text with many new perspectives and a sense of ‘purpose.’” (Blair A. Jobe, Journal of Gastrointestinal Cancer, Vol. 43, 2012)
()